MedPath

Paravertebral block versus thoracic epidural analgesia for video-assisted thoracic surgery

Not Applicable
Completed
Conditions
Pain in the postoperative period
Surgery
Registration Number
ISRCTN20639281
Lead Sponsor
Second Affiliated Hospital of Zhejiang University
Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37573993/ (added 06/06/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
176
Inclusion Criteria

Patients diagnosed with solitary pulmonary nodules and without chronic pain (with no pain medications routinely used) deemed suitable to undergo three-port single-intercostal VATS by surgeons

Exclusion Criteria

Patients with other malignancies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain measured using the visual analogue score (VAS) in the state of rest and coughing postoperatively at 1, 6, 24, 48, and 72 hours
Secondary Outcome Measures
NameTimeMethod
1. The number of patients who required rescue medication and the cumulative dezocine dose administered during postoperative days (PODs) 0-3, recorded at 8:00 on PODs 1-4<br>2. Quality of life measured using the European Organization for Research and Treatment of Cancer (EORCT) general quality of life questionnaire (QLQ-C30) within 1 days prior to surgery, 3 days after the operation<br>3. Overall satisfaction with analgesic modality measured using a 5-point scale (1=dissatisfied, 5=satisfied) on POD 3<br>4. Complications after surgery, such as nausea and vomiting, hypertension, chylothorax and atrial fibrillation, recorded after surgery and before discharge
© Copyright 2025. All Rights Reserved by MedPath